Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nanexa | NANEXA | Apr 30, 2024 | 0.70 | +12.90 |
Nanologica | NICA | Apr 30, 2024 | 5.70 | +1.06 |
NextCell Pharma AB | NXTCL | Apr 30, 2024 | 1.34 | +1.13 |
Nykode Therapeutics | NYKDO | Apr 30, 2024 | 13.05 | 0.00 |
ODI Pharma | ODI | Apr 30, 2024 | 5.70 | 0.00 |
Oncopeptides | ONCO | Apr 30, 2024 | 2.91 | -1.69 |
OncoZenge | ONCOZ | Apr 30, 2024 | 3.72 | +1.36 |
OptiCept Technologies | OPTI | Apr 30, 2024 | 2.50 | -2.53 |
Orexo | ORX | Apr 30, 2024 | 16.90 | +2.67 |
OssDsign | OSSD | Apr 30, 2024 | 9.74 | -0.10 |
Peptonic Medical | PMED | Apr 30, 2024 | 0.02 | 0.00 |
PharmaLundensis | PHAL | Apr 30, 2024 | 0.70 | +5.74 |
Pila Pharma | PILA | Apr 30, 2024 | 2.43 | +4.29 |
Polymer Factory Sweden | POLYMER | Apr 30, 2024 | 0.72 | 0.00 |
Probi | PROB | Apr 30, 2024 | 203.00 | 0.00 |
Promimic AB | PRO | Apr 30, 2024 | 27.20 | -0.37 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | Apr 30, 2024 | 0.10 | +17.95 |
RaySearch Laboratories B | RAYB | Apr 30, 2024 | 120.60 | +1.17 |
Redwood Pharma | REDW | Apr 30, 2024 | 0.95 | +0.21 |
Respiratorius | RESP | Apr 30, 2024 | 0.24 | -7.45 |
Saniona | SANION | Apr 30, 2024 | 1.82 | -1.09 |
Scandinavian ChemoTech B | CMOTECB | Apr 30, 2024 | 2.23 | 0.00 |
Scandion Oncology | SCOL | Apr 30, 2024 | 1.35 | -3.93 |
Spago Nanomedical | SPAGO | Apr 30, 2024 | 0.37 | +2.22 |
Sprint Bioscience | SPRINT | Apr 30, 2024 | 1.33 | +1.84 |
Stayble Therapeutics | STABL | Apr 30, 2024 | 0.23 | -4.18 |
Stenocare | STENO | Apr 30, 2024 | 5.10 | -0.39 |
Swedish Orphan Biovitrum | SOBI | Apr 30, 2024 | 285.40 | +0.71 |
SynAct Pharma AB | SYNACT | Apr 30, 2024 | 6.84 | -0.94 |
Toleranzia | TOL | Apr 30, 2024 | 0.52 | -0.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.